Back to
Allianz Asset Management GmbH
CORT
Showing 8 of 21 quarters
Position history for
Allianz Asset Management GmbH's holdings in Corcept Therapeutics Incorporated
Yes. Allianz Asset Management holds 89,152 shares of CORT (Corcept Therapeutics), worth $7.8M, as of its Q2 2026 13F filing. The share count is unchanged from Q1 2026. Allianz Asset Management has held CORT since Q4 2022, across 15 quarterly 13F filings.
Current Value
$7.8M
Current Shares
89,152
Total Value Change
+$513,574
Total Shares Change
-67,248
Quarter-by-Quarter History
Other major holders of CORT: BlackRock, Inc., Vanguard Group Inc.